Metaplasia: all 99 studies
Page 1 of 1. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.
- The Gastric HormonE BioMarkers of Preneoplastic Lesions StudyNot yet recruitingNCT06085677
- Intestinal Metaplasia Cohort for Gastric Cancer PredictionRecruitingNCT06075199
- Intestinal Flora and Metabonomics of AppendicitisRecruitingNCT06035029
- The Prevalence, Risk Factors and Optimal Biopsy Protocol of BERecruitingNCT05818072Not applicable
- Cytosponge for Gastric Intestinal MetaplasiaRecruitingNCT05657080
- Automatic Evaluation of the Severity of Gastric Intestinal Metaplasia With Pathology Artificial Intelligence Diagnosis SystemRecruitingNCT05447221
- Pyloric or Pseudopyloric Metaplasia of the Corpus Mucosa in Autoimmune GastritisEnrolling by invitationNCT05238181
- SUrveillance of PREMalignant Stomach - Individualized Endoscopic Follow-upRecruitingNCT04613570Not applicable
- AG & IM in CA Stomach ProtocolRecruitingNCT04184960
- Surveillance of Patients With Precancerous Lesions of the StomachRecruitingNCT03250091
- Volatiles in Breath and Headspace Analysis - Diagnostic MarkersEnrolling by invitationNCT03228095
- The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort StudyNot yet recruitingNCT02933229Phase 4
- Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency AblationTerminatedNCT02162758Phase 2Results posted
- Acetic Acid Chromoendoscopy to Judge Gastric Intestinal MetaplasiaCompletedNCT01499576Not applicableResults posted
- Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or CholangiocarcinomaCompletedNCT01093222Phase 2Results posted
- Micro-Layer Ablation of Barrett's Metaplasia- A Two-Phase, Multi-Center Trial - Extension of Follow-up to 5 YearsCompletedNCT00489268Not applicableResults posted
- A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid MetaplasiaCompletedNCT00463385Phase 2Results posted
- A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's MetaplasiaCompletedNCT00357682Phase 3Results posted
- Ablation of Intestinal Metaplasia Containing DysplasiaCompletedNCT00282672Not applicableResults posted
- Atrophic Gastritis and OLGIM StageCompletedNCT06585553
- Gastric Cancer Endoscopic Screening in an Intermediate-risk Country - ROGCAS, a Dual-centre Pilot ProgramCompletedNCT06316882
- A Study on the Relationship Between Gastric Xanthoma and Gastric Cancer and Precancerous LesionsCompletedNCT06282484
- Evaluation of Antral Biopsies Obtained in Normal EsophagogastroduodenoscopyCompletedNCT06269380Not applicable
- Artificial Intelligence for Determination of Gastroscopy Surveillance IntervalsStatus unknownNCT05631015
- Systems Biology of Gastrointestinal and Related DiseasesTerminatedNCT05579444
- Validation the Artificial Intelligence System for Automatic Evaluation of the Extent of Intestinal MetaplasiaCompletedNCT05464108
- Automatic Evaluation of the Extent of Intestinal Metaplasia With Artificial IntelligenceStatus unknownNCT05459610
- Artificial Intelligence Confocal Laser Endomicroscopy for Real-time Assessment of Gastric Cancer Risk.Status unknownNCT05459428
- Endoscopic Grading of Intestinal MetaplasiaCompletedNCT05345314
- Metformin Efficacy and Safety for Gastric Intestinal MetaplasiaCompletedNCT05288153Phase 4
- Ablation of Esophageal Inlet Patches in Patients Referred for Bravo pH-TestingStatus unknownNCT05131932Not applicable
- Validation of an Artificial Intelligence System Based on Raman Spectroscopy for Diagnosis of Gastric Premalignant Lesions and Early Gastric CancerStatus unknownNCT04869618Not applicable
- Diagnostic Performance Indicators in Upper GI Endoscopy:PROSPERO StudyStatus unknownNCT04843397
- Reversal of Preneoplastic Metaplasia in the Stomach With MEK InhibitorActive, not recruitingNCT04454476Phase 1
- Microbiome Analysis in Gastric Intestinal Metaplasia and in Gastric Cancer and Subtypes CorrelationStatus unknownNCT04365946
- RFA for GIM TreatmentCompletedNCT04348266Not applicable
- Sensitivity of Targeted Biopsy Within Sydney Protocol for GIMStatus unknownNCT04331951Not applicable
- Diagnosis of Gastritis, H. Pylori Infection and Atrophic Gastritis in Dyspeptic PatientsCompletedNCT04296513
- Novel Approach to Surveillance of Gastric LesionsStatus unknownNCT04251403Early Phase 1
- Acetic Acid for the Detection of Esophageal NeoplasmsSuspendedNCT04054713Not applicable
- Study on the Effect of Bile Reflux on Gastric Cancer and Its Precancerous Lesions: a Cross-sectional Study.CompletedNCT03976739
- Confocal Laser Endomicroscopy With Cresyl Violet for in Vivo Diagnosis of Gastric Intestinal MetaplasiaCompletedNCT03672708Not applicable
- Predict Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal MetaplasiaWithdrawnNCT03670134Not applicable
- OLGA and OLGIM Stage System for Gastric CancerCompletedNCT03380052
- An Exploratory Clinical Study of Apatinib for the 2nd Treatment of Esophageal Cancer or Esophageal and GastricStatus unknownNCT03285906Phase 2/3
- Gastric Cancer Precursor Lesions (GCPL) StudyCompletedNCT03188406
- The Efficacy of Probe-based Confocal Laser Endomicroscopy in Staging OLGIMStatus unknownNCT02932735
- A Comparison of pCLE Based Targeted Biopsy and WLE Based Standard Biopsy in Staging the Operative Link on Gastric Intestinal Metaplasia (OLGIM): A Randomized，Cross-over StudyStatus unknownNCT02930616Phase 4
- pCLE in the Detection of Esophageal and Gastric Lesions and Intestinal Metaplasia or Dysplasia in Patients After Endoscopic Treatment of BORNCompletedNCT02922049Not applicable
- Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux DiseaseCompletedNCT02890979Not applicable
- Gene Expression Profiling in Human Gastric Intestinal Metaplasia Mucosa and Duodenal MucosaCompletedNCT02846688
- Difference of Gastric Microbiota in the Process of Correa's Model.Status unknownNCT02833363
- The Efficacy of Severe Whitening and Delayed Fading in Acetic Acid-enhanced Endoscopy for Diagnosing Gastric Intestinal MetaplasiaStatus unknownNCT02806115Phase 1
- Helicobacter Pylori Genome Project (HpGP)TerminatedNCT02788214
- Diagnosis of Gastric Intestinal Metaplasia With High Definition Endoscopy and Optic EnhancementStatus unknownNCT02725034Not applicable
- Oxidative Stress in Intestinal Metaplasia and Metabolic SyndromeStatus unknownNCT02695186
- Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean PatientsCompletedNCT02691637
- Confocal Laser Endomicroscopy vs Conventional Histology for the Identification of Intestinal MetaplasiaCompletedNCT02632682
- Different Fluorescein Sodium Dosage for the Detection of Gastric Intestinal MetaplasiaStatus unknownNCT02534818Phase 4
- I-scan With Magnification for the Detection of Gastric Intestinal MetaplasiaStatus unknownNCT02516735Not applicable
- PCLE for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and CarcinomaStatus unknownNCT02515721Not applicable
- Gastric Cancer Screening Quality Improvement System EstablishmentStatus unknownNCT02457624
- Mucosal Microbiome in Human Gastric Intestinal Metaplasia and Duodenal Tissue.Status unknownNCT02428426
- Volatile Markers in Digestive CancerCompletedNCT02332213
- Prognosis and Risk Factors of Gastric Cancer in Patients With Intestinal MetaplasiaStatus unknownNCT02325323
- Narrow Band Imaging for Gastric NeoplasiaStatus unknownNCT02197351Not applicable
- Evaluation of Immunological Disorders of T Lymphocytes and Endocrinological Disorders as Pathogen Factors in Patients With Metaplasia of Urinary BladderCompletedNCT02092558
- Tamoxifen to Treat Barrett's MetaplasiaTerminatedNCT02089386Early Phase 1
- Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient ManagementCompletedNCT02075905
- Association Between Confocal Laser Endomicroscopic (CLE) Features and Gastric Mucosal MicrobiomeStatus unknownNCT02063932
- Effect of Zinc on Barrett's MetaplasiaStatus unknownNCT01984580Phase 1
- RCT: WLE vs. NBI in Upper Gastrointestinal EndoscopyCompletedNCT01945177Not applicable
- New Classification of Stomach Using Probe-based Confocal Laser EndomicroscopyCompletedNCT01896310
- Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By SurgeryWithdrawnNCT01859182Phase 2
- Long-term Follow-up Prognosis of Atrophic Gastritis After 3 YearsCompletedNCT01824953
- Prevalence of Dysplasia of the Gastric CardiaCompletedNCT01787864
- Confocal Laser Endomicroscopy for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and CarcinomaStatus unknownNCT01642797Not applicable
- Radiofrequency Ablation for Gastric Metaplasia and DysplasiaCompletedNCT01614418Phase 1/2
- The Learning Curve of Probe-based Confocal Laser Endomicroscopy (pCLE) Images Interpretation in Gastric Intestinal Metaplasia (GIM)Status unknownNCT01491724
- The Predictive Scores for Gastric Cancer in Gastric Intestinal Metaplasia (GIM) Patient: a Recommendation for Thai PopulationStatus unknownNCT01490541
- Magnified Intelligence Chromoendoscopy Plus Probe-based Confocal Laser Endomicroscopy for Gastric Intestinal Metaplasia DiagnosisCompletedNCT01489397Not applicable
- Comparison Between Probe-based Confocal Laser Endomicroscopy, White-light Endoscopy and Virtual ChromoendoscopyStatus unknownNCT01398579Phase 1
- Confocal Endomicroscopy Detection of Gastric Preneoplasia and NeoplasiaCompletedNCT01384201
- Racial Disparity in Barrett's EsophagusCompletedNCT01374074
- Is the Neosquamous Epithelium "Normal" Following Endoscopic Ablation of Dysplastic Barrett's Esophagus?CompletedNCT01373125
- Confocal Laser Endomicroscopy for the Detection of Gastric Intestinal Metaplasia: a Randomized Controlled TrialCompletedNCT01024621Not applicable
- Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the LungTerminatedNCT01013831Phase 1
- A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic MalignanciesCompletedNCT00807677Phase 1
- The Role of Narrow-Band Imaging Endoscopy in Diagnosing Gastric Intestinal MetaplasiaStatus unknownNCT00673699
- Optical Coherence Tomography of the Gastrointestinal TractCompletedNCT00579748
- A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic MalignanciesCompletedNCT00506402Phase 1
- Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid MetaplasiaCompletedNCT00445900Phase 2
- Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Myelofibrosis With Myeloid MetaplasiaCompletedNCT00360035Phase 2
- A Trial of Zoledronic Acid in Patients With Myelofibrosis With Myeloid Metaplasia (MMM)CompletedNCT00287261Phase 2
- S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or CholangiocarcinomaCompletedNCT00238212Phase 2
- Esophageal Metaplasia Using a Novel Antibody: Reversibility by Proton Pump InhibitorTerminatedNCT00161200Phase 3
- PTK 787 and Gleevec in Patients With AML, AMM, and CML-BPCompletedNCT00088231Phase 1/2
- Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED)CompletedNCT00086125Phase 2
- Tipifarnib in Treating Patients With Myelofibrosis and Myeloid MetaplasiaCompletedNCT00047190Phase 2